|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1995-6-20
|
|
pubmed:abstractText |
To determine the safety, pharmacokinetics, and magnetic resonance (MR) imaging results of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA) as a contrast agent for use in hepatobiliary MR imaging.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0033-8419
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
195
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
785-92
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:7754011-Adult,
pubmed-meshheading:7754011-Biliary Tract,
pubmed-meshheading:7754011-Contrast Media,
pubmed-meshheading:7754011-Double-Blind Method,
pubmed-meshheading:7754011-Gadolinium DTPA,
pubmed-meshheading:7754011-Humans,
pubmed-meshheading:7754011-Liver,
pubmed-meshheading:7754011-Magnetic Resonance Imaging,
pubmed-meshheading:7754011-Male,
pubmed-meshheading:7754011-Organometallic Compounds,
pubmed-meshheading:7754011-Pentetic Acid
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging.
|
|
pubmed:affiliation |
Department of Radiology, Charité Hospital, Humboldt-Universität zu Berlin, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Clinical Trial, Phase I
|
